NCT00308074 An Open-Label Trial of Aripiprazole in Autism Spectrum Disorders Status COMPLETED Phase PHASE2
NCT00271622 The Neurodevelopmental and Behavioral Phenotyping Screening Protocol Status RECRUITING Phase N/A
NCT00263796 An fMRI Study of the Effect of Intravenous Oxytocin vs. Placebo on Response Inhibition and Face Processing in Autism Status COMPLETED Phase PHASE1
NCT00263367 Effect of Hyperbaric Therapy on Markers of Oxidative Stress in Children With Autism Status COMPLETED Phase NA
NCT00251303 Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum Disorders Status COMPLETED Phase PHASE2
NCT00247156 An Autism Study Using Nambudripad's Food Allergy Elimination Treatments Status COMPLETED Phase PHASE1/PHASE2
NCT00227487 Intestinal Inflammation and Carbohydrate Digestion in Autistic Children Status UNKNOWN Phase NA
NCT00211783 Functional Magnetic Resonance Imaging (fMRI) for the Study of Response Inhibition, and Face and Linguistic Processing in Autism Status COMPLETED Phase N/A
NCT00211770 Use of Functional Behavioral Assessments to Evaluate Stereotypy and Repetitive Behaviors in a Double-blind, Placebo Controlled Trials of Various Medications Used to Treat Children With Autism. Status COMPLETED Phase N/A
NCT00211757 Divalproex Sodium vs. Placebo in Childhood/Adolescent Autism Status COMPLETED Phase PHASE2
NCT00183404 Long-Term Olanzapine Treatment in Children With Autism Status COMPLETED Phase PHASE2/PHASE3
NCT00178503 Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children Status COMPLETED Phase PHASE2/PHASE3
NCT00166621 Early Pharmacotherapy Aimed at Neuroplasticity in Autism : Safety and Efficacy Status COMPLETED Phase PHASE1/PHASE2
NCT00161135 Magnetic Resonance Imaging in Children and Adolescents With Autism and Multiple Complex Developmental Disorders Status COMPLETED Phase N/A